Seeking Alpha

Novartis considering sale of animal-health, OTC drug, vaccine businesses: Bloomberg

  • Novartis (NVS +1.2%may consider selling its animal-health business as part of a portfolio review the company is conducting with the help of Goldman, people familiar with the matter tell Bloomberg.
  • Although no decisions are final, the sources also suggest the OTC medicines business and the vaccines unit are also candidates for a possible sale.
  • According the Cit estimates, the animal-health business is worth around $4B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)